Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium

被引:14
作者
De Logu, A
Uda, P
Pellerano, ML
Pusceddu, MC
Saddi, B
Schivo, ML
机构
[1] Univ Cagliari, Dipartimento Sci Chirurg & Trapianti Organo, I-09123 Cagliari, Italy
[2] Trinita ASL 8, Lab Anal Osped SS, I-09100 Cagliari, Italy
关键词
D O I
10.1007/s10096-001-8039-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The usefulness of two colorimetric methods for the determination of the susceptibility or resistance of Mycobacterium tuberculosis to rifampin, streptomycin, and isoniazid in liquid medium based on the reduction of 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide (XTT) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was investigated. The agar proportion method was used as the reference method. Results obtained indicate that the sensitivity of the XTT reduction assay for the detection of rifampin resistance was comparable to that observed, and previously described, for the MTT assay. However, the reduction of XTT yields a water-soluble formazan that can be easily quantified without performing additional steps such as addition of lysing buffer and solubilization. Furthermore, the colorimetric assays, based on the reduction of XTT and MTT for the detection of isoniazid and streptomycin resistance in Mycobacterium tuberculosis, were standardized. The inhibition of MTT and XTT reduction after treatment with rifampin, streptomycin, or isoniazid was directly proportional to the reduction in the number of viable bacteria, and a strain of Mycobacterium tuberculosis could be reported as susceptible or resistant to rifampin, streptomycin, or isoniazid after 3, 6, or 8 days, respectively. The XTT and MTT reduction assays are rapid, reliable, and affordable and do not require the use of radioisotopes. Moreover, they can be performed with common laboratory equipment.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 25 条
[1]  
Abate G, 1998, INT J TUBERC LUNG D, V2, P1011
[2]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[3]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[4]   Surveillance of drug resistance for tuberculosis control: Why and how? [J].
Chaulet, P ;
Boulahbal, F ;
Grosset, J .
TUBERCLE AND LUNG DISEASE, 1995, 76 (06) :487-492
[5]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[6]  
FALLON RJ, 1996, PRACTICAL MED MICROB, P37
[7]   AN OUTBREAK OF TUBERCULOSIS CAUSED BY MULTIPLE-DRUG-RESISTANT TUBERCLE-BACILLI AMONG PATIENTS WITH HIV-INFECTION [J].
FISCHL, MA ;
UTTAMCHANDANI, RB ;
DAIKOS, GL ;
POBLETE, RB ;
MORENO, JN ;
REYES, RR ;
BOOTA, AM ;
THOMPSON, LM ;
CLEARY, TJ ;
LAI, SH .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (03) :177-183
[8]   DETERMINATION OF MICS FOR MYCOBACTERIUM-AVIUM MYCOBACTERIUM-INTRACELLULARE COMPLEX IN LIQUID-MEDIUM BY A COLORIMETRIC METHOD [J].
GOMEZFLORES, R ;
GUPTA, S ;
TAMEZGUERRA, R ;
MEHTA, RT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1842-1846
[9]   RE-EXAMINATION AND FURTHER DEVELOPMENT OF A PRECISE AND RAPID DYE METHOD FOR MEASURING CELL-GROWTH CELL KILL [J].
HANSEN, MB ;
NIELSEN, SE ;
BERG, K .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 119 (02) :203-210
[10]   Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the Standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents [J].
Hawser, SP ;
Norris, H ;
Jessup, CJ ;
Ghannoum, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) :1450-1452